catechin and Diabetic Angiopathies

catechin has been researched along with Diabetic Angiopathies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, L; Tang, L; Yang, J; Zeng, C1
Balakumar, P; Bhardwaj, P; Khanna, D1
Lombo, C; Morgado, C; Neves, D; Tavares, I1
Cai, Q; Gao, HQ; Li, BY; Wang, JF; Yin, M; Yu, F; Zhang, JH; Zhang, Z1

Other Studies

4 other study(ies) available for catechin and Diabetic Angiopathies

ArticleYear
Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2017, Aug-17, Volume: 50, Issue:10

    Topics: Catechin; Diabetic Angiopathies; Humans; Protective Agents

2017
Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Cardiovascular toxicology, 2014, Volume: 14, Issue:1

    Topics: Animals; Aorta; Blood Glucose; Catechin; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Female; Lipid Peroxidation; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Phosphatidylinositol 3-Kinase; Rats; Rats, Wistar; Superoxides; Vasodilation; Vasodilator Agents

2014
Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.
    International journal of impotence research, 2016, Volume: 28, Issue:4

    Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Male; Muscle, Smooth; Penis; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2016
Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products.
    Bioscience, biotechnology, and biochemistry, 2011, Volume: 75, Issue:9

    Topics: Antioxidants; Aorta; Apoptosis; Biflavonoids; Catechin; Cell Movement; Cell Proliferation; Diabetes Mellitus; Diabetic Angiopathies; Glycation End Products, Advanced; Grape Seed Extract; Humans; I-kappa B Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Proanthocyanidins; Reactive Oxygen Species; Signal Transduction; Ubiquitin Thiolesterase; Vitis

2011